Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting. [electronic resource]
Producer: 20130103Description: 472-7 p. digitalISSN:- 1934-2403
- Adamantane -- adverse effects
- Adult
- Aged
- Aged, 80 and over
- Diabetes Mellitus, Type 2 -- blood
- Dipeptides -- adverse effects
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Drug Monitoring
- Exenatide
- Female
- Glucagon-Like Peptide 1 -- agonists
- Glucagon-Like Peptide-1 Receptor
- Humans
- Hypoglycemic Agents -- adverse effects
- Lipase -- blood
- Male
- Middle Aged
- Pancreas -- drug effects
- Pancreatic alpha-Amylases -- blood
- Pancreatitis -- chemically induced
- Peptides -- adverse effects
- Pyrazines -- adverse effects
- Receptors, Glucagon -- agonists
- Reproducibility of Results
- Severity of Illness Index
- Sitagliptin Phosphate
- Triazoles -- adverse effects
- Venoms -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.